BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹30 Cr | ₹31 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr |
What is the latest Operating Profit of BAL PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹30 Cr |
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹25 Cr |
How is Operating Profit of BAL PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 Cr | -3.80 | |
| Mar2025 | ₹31 Cr | 22.52 | |
| Mar2024 | ₹25 Cr | 5.30 | |
| Mar2023 | ₹24 Cr | -2.70 | |
| Mar2022 | ₹25 Cr | - | |
Compare Operating Profit of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹147.6 Cr | 8.7% | 3.9% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 8.7% |
3.9% |
1.5% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses